The FDA cleared Parsippany, N.J.-based Onkos Surgical to market its ELEOS Limb Salvage System.
Here are five things to know:
1. Surgeons may now use ELEOS to treat patients with bone loss caused by cancer, trauma or surgical procedures.
2. The system is designed to offer a surgeon flexibility and modularity when performing these complex cases.
3. ELEOS represents a long-term, reconstructive choice for oncology patients.
4. Patrick Treacy, Onkos Surgical founder and CEO, commented they are expecting a full launch of ELEOS in the first quarter of 2017.
5. Founded in 2015, Onkos Surgical is a privately held surgical oncology company.